Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Jacksonville, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Maitland, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Maitland, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
North Miami, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Orlando, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Tampa, FL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Atlanta, GA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Libertyville, IL
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Libertyville, IL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Indianapolis, IN
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Terre Haute, IN
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Terre Haute, IN
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Owensboro, KY
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Owensboro, KY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Toms River, NJ
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Stony Brook, NY
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Cleveland, OH
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Columbus, OH
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Philadelphia, PA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Charleston, SC
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Memphis, TN
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Bellevue, WA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/16/2015
Clinical Research Facility
mi
from
Bothell, WA
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/16/2015
Clinical Research Facility
mi
from
Bothell, WA
Click here to add this to my saved trials
Duloxetine Versus Pregabalin for Alcohol Dependence
Duloxetine Versus Pregabalin for Alcohol Dependence
Status: Enrolling
Updated:  11/17/2015
The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research
mi
from
La Jolla, CA
Duloxetine Versus Pregabalin for Alcohol Dependence
Duloxetine Versus Pregabalin for Alcohol Dependence
Status: Enrolling
Updated: 11/17/2015
The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research
mi
from
La Jolla, CA
Click here to add this to my saved trials
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort
Status: Enrolling
Updated:  11/17/2015
Boston Med Ctr
mi
from
Boston, MA
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort
Status: Enrolling
Updated: 11/17/2015
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/17/2015
QPS MRA
mi
from
Miami, FL
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/17/2015
QPS MRA
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/17/2015
Houston Clinical Research
mi
from
Houston, TX
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/17/2015
Houston Clinical Research
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  11/17/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
A Phase 1, Open-label Study of the Pharmacokinetics of d- and L-amphetamine After a Single Dose of SHP465 12.5 mg or 25 mg Administered to Children and Adolescents Aged 6 to17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 11/17/2015
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Self-Defense Training in Women With Trauma
A Pilot Study of Self-Defense Training in Women With Trauma
Status: Enrolling
Updated:  11/18/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Self-Defense Training in Women With Trauma
A Pilot Study of Self-Defense Training in Women With Trauma
Status: Enrolling
Updated: 11/18/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Family-based Crisis Intervention With Suicidal Adolescents in the ED
Family-based Crisis Intervention With Suicidal Adolescents in the Emergency Department: A Randomized Clinical Trial
Status: Enrolling
Updated:  11/18/2015
Boston Children's Hospital
mi
from
Boston, MA
Family-based Crisis Intervention With Suicidal Adolescents in the ED
Family-based Crisis Intervention With Suicidal Adolescents in the Emergency Department: A Randomized Clinical Trial
Status: Enrolling
Updated: 11/18/2015
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents
Early Identification and Treatment of Anorexia Nervosa
Status: Enrolling
Updated:  11/19/2015
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents
Early Identification and Treatment of Anorexia Nervosa
Status: Enrolling
Updated: 11/19/2015
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality
Status: Enrolling
Updated:  11/19/2015
VA Puget Sound Health Care System
mi
from
Tacoma and Seattle, WA
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality
Status: Enrolling
Updated: 11/19/2015
VA Puget Sound Health Care System
mi
from
Tacoma and Seattle, WA
Click here to add this to my saved trials
Treating PTSD in Patients With Borderline Personality Disorder
Treating PTSD in Patients With Borderline Personality Disorder
Status: Enrolling
Updated:  11/20/2015
Behavioral Research and Therapy Clinics, University of Washington
mi
from
Seattle, WA
Treating PTSD in Patients With Borderline Personality Disorder
Treating PTSD in Patients With Borderline Personality Disorder
Status: Enrolling
Updated: 11/20/2015
Behavioral Research and Therapy Clinics, University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Homewood, AL
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Homewood, AL
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Glendora, CA
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Glendora, CA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
San Diego, CA
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Denver, CO
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Farmington, CT
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Farmington, CT
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Orlando, FL
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Orlando, FL
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Shreveport, LA
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Shreveport, LA
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Troy, MI
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Troy, MI
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Garden City, NY
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Garden City, NY
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMS Site
mi
from
Winston Salem, NC
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMS Site
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Toledo, OH
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Toledo, OH
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Desoto, TX
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Desoto, TX
Click here to add this to my saved trials
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated:  11/20/2015
AQX/CMX site
mi
from
Calgary,
Efficacy and Safety of AQX-1125 in IC/BPS
A Phase 2 Study to Evaluate the Efficacy and Safety of AQX-1125 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Mediated by the Src Homology-2-domain-containing Inositol 5' Phosphatase [SHIP1] Pathway
Status: Enrolling
Updated: 11/20/2015
AQX/CMX site
mi
from
Calgary,
Click here to add this to my saved trials
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
Status: Enrolling
Updated:  11/21/2015
University of Tennessee Medical Center
mi
from
Knoxville, TN
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
Status: Enrolling
Updated: 11/21/2015
University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated:  11/23/2015
Clark Center for Urogynecology
mi
from
Newport Beach, CA
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated: 11/23/2015
Clark Center for Urogynecology
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated:  11/23/2015
Female Pelvic & Urogynecology Institute of Michigan, Grand Rapids Womens Health
mi
from
Grand Rapids, MI
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated: 11/23/2015
Female Pelvic & Urogynecology Institute of Michigan, Grand Rapids Womens Health
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated:  11/23/2015
Princeton Urogynecology
mi
from
Princeton, NJ
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated: 11/23/2015
Princeton Urogynecology
mi
from
Princeton, NJ
Click here to add this to my saved trials
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated:  11/23/2015
Institute for Female Pelvic Medicine and Reconstructive Surgery
mi
from
Allentown, PA
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated: 11/23/2015
Institute for Female Pelvic Medicine and Reconstructive Surgery
mi
from
Allentown, PA
Click here to add this to my saved trials
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated:  11/23/2015
Manjon Gynecology
mi
from
Harrisburg, PA
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated: 11/23/2015
Manjon Gynecology
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated:  11/23/2015
Southern Uroynecology
mi
from
West Columbia, SC
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence
Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)
Status: Enrolling
Updated: 11/23/2015
Southern Uroynecology
mi
from
West Columbia, SC
Click here to add this to my saved trials